Inexpensive and Favorably Reviewed S&P 500 Stocks for June

Investing in the stock market can be a daunting task, especially with the constant fluctuations and uncertainties in the market. However, there are always opportunities to find undervalued stocks that have the potential for growth. At Extreme Investor Network, we have identified some stocks that may be selling at attractive valuations right now and could be worth considering for your investment portfolio.

Despite recent declines in the market, the S&P 500 is still up 4.3% for the month, showing signs of strength in certain sectors. Using our CNBC Pro Stock Screener Tool, we have identified stocks that are considered “cheap” relative to the broader market and meet specific criteria, such as a forward price-to-earnings ratio below the S&P 500’s 21, consensus buy rating, and upside to analysts’ consensus price target of 25% or more.

Related:  Bernstein lowers Boeing's rating due to labor strike impacting future prospects

One stock that stands out is Global Payments, a financial services company that has seen a decline of more than 20% this year. However, with a low forward price-to-earnings ratio of roughly 8.6, the company has the highest expected upside of about 48%. Despite concerns about margins, analysts believe there is potential for growth in the near future.

Ulta Beauty is another stock that our analysis has identified as undervalued. With a forward price-to-earnings ratio of 14.5 and a consensus buy rating, analysts believe there is a potential upside of 32%. Despite recent declines in the stock price, there is still optimism about the company’s future prospects.

Related:  Wall Street Analysts Select Three Dividend Stocks for Increased Returns

General Motors, a well-known automotive manufacturer, also presents an interesting opportunity for investors. With a forward price-to-earnings ratio of 4.4, the company has the lowest valuation of the group. Analysts have a consensus buy rating on GM and anticipate a 26% increase in the stock price over the next 12 months.

Other stocks on our list include FedEx, Halliburton, and health-care companies like Biogen, Gilead Sciences, and CVS Health. These companies all meet our criteria for undervalued stocks with potential for growth.

At Extreme Investor Network, we strive to provide valuable insights and analysis to help you make informed investment decisions. By identifying undervalued stocks that have the potential for growth, we aim to help our readers navigate the complex world of investing and maximize their returns. Stay tuned for more updates and recommendations on the latest investment opportunities in the market.

Related:  Introduction to Nvidia and Other Leading Semiconductor Stocks

Source link